ArticleCancer chemotherapy and pharmacology2013

Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer.

Christopher M Stephenson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.